Cellectis (CLLS) Total Liabilities (2014 - 2026)
Cellectis (CLLS) recorded quarterly Total Liabilities of $229.3 million in Q1 2026, down 7.86% quarter-over-quarter from $248.8 million in Q4 2025, and down 7.51% on a YoY basis from $247.9 million in Q1 2025.
Cellectis (CLLS) Total Liabilities (2014 - 2026) Analysis & Trends
Cellectis' Total Liabilities history runs 13 years deep, the most recent figure standing at $229.3 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 7.51% year-over-year to $229.3 million; the TTM figure through Mar 2026 stood at $229.3 million (down 7.51% YoY), while the FY2025 annual figure was $248.8 million, down 1.46% from the prior year.
- Total Liabilities was $229.3 million for Q1 2026 at Cellectis, down from $248.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $266.5 million in Q3 2024 to a low of $15.2 million in Q4 2022.
- Historically, Total Liabilities has averaged $191.3 million across 5 years, with a median of $242.6 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities slumped 87.04% in 2022, then jumped 1543.24% in 2023.
- A 5-year view of Total Liabilities shows it stood at $15.2 million in 2022, then jumped by 1543.24% to $249.6 million in 2023, then climbed by 1.18% to $252.5 million in 2024, then declined by 1.46% to $248.8 million in 2025, then slipped by 7.86% to $229.3 million in 2026.
- The last three Total Liabilities figures came in at $229.3 million (Q1 2026), $248.8 million (Q4 2025), and $242.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | 229.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.27 Mn |
| Dec 31, 2025 | 248.82 Mn |
| Sep 30, 2025 | 242.57 Mn |
| Jun 30, 2025 | 256.86 Mn |
| Mar 31, 2025 | 247.88 Mn |
| Dec 31, 2024 | 252.51 Mn |
| Sep 30, 2024 | 266.45 Mn |
| Jun 30, 2024 | 258.54 Mn |
| Mar 31, 2024 | 263.89 Mn |
| Dec 31, 2023 | 249.58 Mn |
| Sep 30, 2023 | 133.58 Mn |
| Jun 30, 2023 | 131.12 Mn |
| Mar 31, 2023 | 137.67 Mn |
| Dec 31, 2022 | 15.19 Mn |
| Sep 30, 2022 | 142.94 Mn |
| Jun 30, 2022 | 151.95 Mn |
| Mar 31, 2022 | 23.42 Mn |
| Dec 31, 2021 | 23.06 Mn |
| Sep 30, 2021 | 174.92 Mn |
| Jun 30, 2021 | 181.70 Mn |